Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Updated daily

Drug recalls

Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.

Class IIOngoingMay 3, 2023CBD Metered Dose InhalerMarketed Without an Approved NDA/ANDAWellness BioSciences · D-0541-2023Class IICompletedMay 3, 2023Pantoprazole sodium for Injection 40 mg*/vialCGMP Deviations; The impacted product and lot number was inadvertently placed into saleable inventory, which does not comply with approved procedures.Methapharm Inc · D-0540-2023Class IIOngoingApr 26, 2023Aripiprazole TabletsOut of specification (OOS) for Spectroscopic Identification test by IR.Ascend Laboratories, LLC · D-0539-2023Class IIOngoingApr 26, 2023C-Semaglutide 5mg/mL injectionLack of assurance of sterility.Pharmacy Plus, Inc. dba Vital Care Compounder · D-0538-2023Class IIOngoingApr 26, 2023Fast Acting Earwax Removal SystemCGMP Deviations: active ingredient may be subpotent before the labeled expiry due to degradation.Pharma Nobis LLC · D-0537-2023Class IITerminatedApr 26, 2023Verapamil Hydrochloride Extended-Release TabletsFailed Dissolution Specifications: Out of specification dissolution results above specified values.Amerisource Health Services LLC · D-0536-2023Class IIIOngoingApr 19, 2023Epinephrine Professional EMSLabeling; Incorrect NDC number on outer carton of product.Focus Health Group Inc · D-0535-2023Class IIIOngoingApr 19, 2023MEKTOVILabeling: Incorrect or Missing Lot and/or Exp Date: The carton and bottle labels state an expiry date of March 2026; the correct expiration date is February 2025.Pfizer Inc. · D-0532-2023Class IIITerminatedApr 19, 2023Bevacizumab 2.5 mg/0.1 mLLabeling: Incorrect or Missing Lot and/or Exp Date: Lot code on primary packaging is incorrect.Pine Pharmaceuticals, LLC · D-0531-2023Class IIOngoingApr 19, 2023Pantoprazole Sodium Delayed Release Tablets USP 40mgCGMP Deviations: DiscolorationHetero USA Inc · D-0530-2023Class IIITerminatedApr 19, 2023Norepinephrine Bitartrate InjectionFailed Impurities/Degradation Specifications: Above the specification limits yielded for related substance norepinephrine sulfonic acid impurity during routine product...Sun Pharmaceutical Industries Inc · D-0529-2023Class IIITerminatedApr 12, 2023Dodex Injectable Cyanocobalamin InjectionSub-potent drug: assay test result below specifications at 9-month timepoint.Accord Healthcare, Inc. · D-0528-2023Class IIOngoingApr 12, 2023Glimepiride Tablets USPcGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.Preferred Pharmaceuticals, Inc. · D-0527-2023Class IIOngoingApr 12, 2023Tadalafil TabletscGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.Preferred Pharmaceuticals, Inc. · D-0526-2023Class IIOngoingApr 12, 2023Simvastatin TabletscGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.Preferred Pharmaceuticals, Inc. · D-0525-2023Class IIOngoingApr 12, 2023Simvastatin TabletscGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.Preferred Pharmaceuticals, Inc. · D-0524-2023Class IIOngoingApr 12, 2023Simvastatin TabletscGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.Preferred Pharmaceuticals, Inc. · D-0523-2023Class IIOngoingApr 12, 2023Simvastatin TabletscGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.Preferred Pharmaceuticals, Inc. · D-0522-2023Class IIOngoingApr 12, 2023Pravastatin Sodium TabletscGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.Preferred Pharmaceuticals, Inc. · D-0521-2023Class IIOngoingApr 12, 2023Rosuvastatin TabletscGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.Preferred Pharmaceuticals, Inc. · D-0520-2023Class IIOngoingApr 12, 2023Rosuvastatin TabletscGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.Preferred Pharmaceuticals, Inc. · D-0519-2023Class IIOngoingApr 12, 2023Montelukast Sodium TabletscGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.Preferred Pharmaceuticals, Inc. · D-0518-2023Class IIOngoingApr 12, 2023Glimepiride TabletscGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.Preferred Pharmaceuticals, Inc. · D-0517-2023Class IIOngoingApr 12, 2023Finasteride TabletscGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.Preferred Pharmaceuticals, Inc. · D-0516-2023Class IIOngoingApr 12, 2023Doxazosin TabletscGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.Preferred Pharmaceuticals, Inc. · D-0515-2023Class IIOngoingApr 12, 2023Doxazosin TabletscGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.Preferred Pharmaceuticals, Inc. · D-0514-2023Class IIOngoingApr 12, 2023Clopidogrel Tablets USPcGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.Preferred Pharmaceuticals, Inc. · D-0513-2023Class IIOngoingApr 12, 2023Atorvastatin Calcium TabletscGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.Preferred Pharmaceuticals, Inc. · D-0512-2023Class IIOngoingApr 12, 2023Atorvastatin Calcium TabletscGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.Preferred Pharmaceuticals, Inc. · D-0511-2023Class IIITerminatedApr 12, 2023Montelukast Sodium Oral Granules USPFailed Impurities/Degradation Specifications: failed impurities for Sulphoxide and Impurity A.Teva Pharmaceuticals USA Inc · D-0510-2023Class IIOngoingApr 12, 2023Alprazolam C-IVCGMP Deviations: Repackaging firm recalling due to potential product cross contamination concerns at the manufacturer.Direct Rx · D-0509-2023Class IIOngoingApr 12, 2023Alprazolam C-IVCGMP Deviations: Repackaging firm recalling due to potential product cross contamination concerns at the manufacturer.Direct Rx · D-0508-2023Class IIOngoingApr 12, 2023Alprazolam C-IVCGMP Deviations: Repackaging firm recalling due to potential product cross contamination concerns at the manufacturer.Direct Rx · D-0507-2023Class IITerminatedApr 12, 2023Alprazolam TabCGMP Deviations: Downstream recall from Breckenridge Pharmaceuticals, Inc due to potential risk of Cross Contamination.Preferred Pharmaceuticals, Inc. · D-0506-2023Class IITerminatedApr 12, 2023Alprazolam TabCGMP Deviations: Downstream recall from Breckenridge Pharmaceuticals, Inc due to potential risk of Cross Contamination.Preferred Pharmaceuticals, Inc. · D-0505-2023Class IITerminatedApr 12, 2023Alprazolam TabCGMP Deviations: Downstream recall from Breckenridge Pharmaceuticals, Inc due to potential risk of Cross Contamination.Preferred Pharmaceuticals, Inc. · D-0504-2023Class IITerminatedApr 12, 2023Simvastatin 40 mg tabletscGMP DeviationsRemedyRepack Inc. · D-0503-2023Class IITerminatedApr 12, 2023Rosuvastatin 40mg tabletscGMP DeviationsRemedyRepack Inc. · D-0502-2023Class IITerminatedApr 12, 2023Rosuvastatin 10mg tabletscGMP DeviationsRemedyRepack Inc. · D-0501-2023Class IITerminatedApr 12, 2023Rosuvastatin 5mg tabletscGMP DeviationsRemedyRepack Inc. · D-0500-2023

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.